At a glance
ClinicalIndex Comparison RecordN/ACompleted· 116,133 enrolled
Drug / intervention
Spiriva Respimatdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Characteristics of Patients Initiating Spiriva Respimat in Asthma in the UK: a Cross-sectional Study Based on the Clinical Practice Research Datalink
In Brief
An observational study evaluating Spiriva Respimat for Asthma. Completed, enrolled 116,133 participants across 1 site.
Detailed Summary
This study is a cross-sectional, non-interventional study based on existing data (NISed).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 2018
Enrollment StartMar 2019
Primary CompletionOct 2019
TodayJul 2026
First PostedOct 2, 2018
Enrollment StartMar 5, 2019
Primary CompletionOct 11, 2019
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.8 years ago
Interventions
Spiriva Respimatdevice
soft-mist inhaler